Comment: Andexanet alfa: A Novel Factor Xa Inhibitor Reversal Agent

被引：3
|
作者：
Gilbert, Brian W. [1 ]
Reeder, Jacob A. [1 ]
机构：
[1] Wesley Med Ctr, Wichita, KS 67214 USA
来源：
ANNALS OF PHARMACOTHERAPY | 2019年 / 53卷 / 11期
关键词：
D O I：
10.1177/1060028019855160
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：1167 / 1167
页数：1
相关论文
共 50 条
  • [1] Andexanet alfa: A Novel Factor Xa Inhibitor Reversal Agent
    Powell, Jason
    Taylor, James
    Garland, Scott G.
    ANNALS OF PHARMACOTHERAPY, 2019, 53 (09) : 940 - 946
  • [2] Andexanet Alfa for Factor Xa Inhibitor Reversal
    Shatzel, Joseph J.
    Daughety, Molly M.
    DeLoughery, Thomas G.
    NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (25): : 2499 - 2499
  • [3] Andexanet Alfa for the Reversal of Factor Xa Inhibitor Activity
    Siegal, Deborah M.
    Curnutte, John T.
    Connolly, Stuart J.
    Lu, Genmin
    Conley, Pamela B.
    Wiens, Brian L.
    Mathur, Vandana S.
    Castillo, Janice
    Bronson, Michele D.
    Leeds, Janet M.
    Mar, Florie A.
    Gold, Alex
    Crowther, Mark A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (25): : 2413 - 2424
  • [4] Andexanet alfa for reversal of direct factor Xa inhibitor anticoagulation
    不详
    AUSTRALIAN PRESCRIBER, 2024, 47 (01) : 31 - 32
  • [5] Andexanet alfa for the reversal of Factor Xa inhibitor related anticoagulation
    Ghadimi, Kamrouz
    Dombrowski, Keith E.
    Levy, Jerrold H.
    Welsby, Ian J.
    EXPERT REVIEW OF HEMATOLOGY, 2016, 9 (02) : 115 - 122
  • [6] Andexanet alfa for reversal of factor Xa inhibitor-associated anticoagulation
    Carpenter, Elise
    Singh, Divita
    Dietrich, Eric
    Gums, John
    THERAPEUTIC ADVANCES IN DRUG SAFETY, 2019, 10
  • [7] Andexanet alfa for the reversal of factor Xa inhibitors
    Favresse, J.
    Hardy, M.
    van Dievoet, M. A.
    Sennesael, A. L.
    Douxfils, J.
    Samama, C. M.
    Vornicu, O.
    Dincq, A. S.
    Lessire, S.
    Mullier, F.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2019, 19 (05) : 387 - 397
  • [8] Andexanet Alfa Use in Cardiac Surgical Patients: A Xa Inhibitor and Heparin Reversal Agent
    Levy, Jerrold H.
    Connors, Jean M.
    JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 2021, 35 (01) : 265 - 266
  • [9] Evaluation of oral factor Xa inhibitor-associated extracranial bleeding reversal with andexanet alfa
    Nederpelt, Charlie J.
    Naar, Leon
    Sylvester, Katelyn W.
    Barra, Megan E.
    Roberts, Russel J.
    Velmahos, George C.
    Kaafarani, Haytham M. A.
    Rosenthal, Martin G.
    King, David R.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2020, 18 (10) : 2532 - 2541
  • [10] Andexanet Alfa for Factor Xa Inhibitor-Associated Intracerebral Hemorrhage Does a Specific Reversal Agent Justify Its Cost?
    Patel, Nikhil
    Morris, Nicholas A.
    NEUROLOGY, 2021, 97 (21) : 971 - 972
12345